Clinical Trial: A Study to Evaluate the Relative Bioavailability of New Formulations of INCB057643 Tablets Administered Orally in Healthy Participants

U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT06941077) titled 'A Study to Evaluate the Relative Bioavailability of New Formulations of INCB057643 Tablets Administered Orally in Healthy Participants' on April 16.

Brief Summary: The purpose of this study is to evaluate the Relative Bioavailability of New Formulations of INCB057643 Tablets Administered Orally in Healthy Participants.

Study Start Date: May 12

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: INCB057643

Tablet

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Incyte Corporation

Disclaimer: Curated by HT Syndication....